This search looks for keywords in all of the website’s content. Search tips
Filter by
PRIME is a scheme run by the European Medicines Agency (EMA) to enhance support for the development of medicines that target an unmet medical need. This voluntary scheme is based on enhanced interaction and early dialogue with developers of promising medicines, to optimise development plans and speed up evaluation so these medicines can reach...
HumanEarly accessRegulatory and procedural guidanceResearch and development
HumanVeterinaryRegulatory and procedural guidanceQuality of medicinesResearch and developmentScientific guidelines
HumanVeterinaryRegulatory and procedural guidanceQuality of medicinesResearch and developmentScientific guidelines
The European Medicines Agency's scientific guidelines on specific types of products help medicine developers prepare marketing authorisation applications for human medicines.
HumanRegulatory and procedural guidanceQuality of medicinesResearch and developmentScientific guidelines
VeterinaryRegulatory and procedural guidanceQuality of medicinesResearch and developmentScientific guidelines
EventHumanClinical trialsQuality of medicinesResearch and development
HumanEarly accessResearch and developmentScientific guidelines
HumanCompassionate useEarly accessRegulatory and procedural guidanceResearch and development
Press releaseHumanCOVID-19Clinical trialsQuality of medicinesResearch and developmentVaccines
NewsHumanCOVID-19Early accessResearch and developmentScientific advice